The PE Ratio as of November 2024 (TTM) for Rallybio Corporation (RLYB) is -0.65

According to Rallybio Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.65. This represents a change of -38.39% compared to the average of -1.06 of the last 4 quarters.

Rallybio Corporation (RLYB) Historical PE Ratio (quarterly & annually)

How has RLYB PE Ratio performed in the past?

The mean historical PE Ratio of Rallybio Corporation over the last ten years is -10.97. The current -0.65 PE Ratio has changed 492.64% with respect to the historical average. Over the past ten years (40 quarters), RLYB's PE Ratio was at its highest in in the June 2024 quarter at -0.92. The PE Ratio was at its lowest in in the March 2020 quarter at -20.20.

Rallybio Corporation (RLYB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rallybio Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rallybio Corporation (RLYB) Average PE Ratio

How has RLYB PE Ratio performed in the past?

The current PE Ratio of Rallybio Corporation (RLYB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Rallybio Corporation (RLYB) PE Ratio vs. Peers

How is RLYB’s PE Ratio compared to its peers?

Rallybio Corporation’s PE Ratio is greater than Century Therapeutics, Inc. (-0.79), greater than Edgewise Therapeutics, Inc. (-24.30), greater than C4 Therapeutics, Inc. (-2.80), greater than Mineralys Therapeutics, Inc. (-4.06), greater than Cullinan Oncology, Inc. (-5.10), greater than Molecular Partners AG (-2.50), greater than AN2 Therapeutics, Inc. (-0.66), greater than Pharvaris N.V. (-8.69), greater than PepGen Inc. (-1.65), greater than PMV Pharmaceuticals, Inc. (-1.61), greater than Opthea Limited (-1.15), greater than Third Harmonic Bio, Inc. (-44.42), greater than Monte Rosa Therapeutics, Inc. (-5.83), greater than Eliem Therapeutics, Inc. (-2.42), less than MediciNova, Inc. (-0.04),

Build a custom stock screener for Rallybio Corporation (RLYB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rallybio Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rallybio Corporation (RLYB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rallybio Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.